TopMedTalk podcast

PUMA Trial: Testing Pulmonary Artery Catheter Avoidance in Low-Risk Cardiac Surgery

19/11/2026
0:00
23:30
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Live from the ANZCA Clinical Trials Network Strategic Workshop, hosts Kate Leslie and Mark Priestly speak with cardiac anesthesia fellow Luke Perry and mentor Lachlan Miles about the PUMA randomized trial evaluating pulmonary artery catheter (PAC) avoidance versus PAC use in low-risk cardiac surgery amid wide practice variation and strong clinician opinions.

Luke Perry is a cardiac anaesthetist and clinician-scientist who serves as a Cardiac Anaesthesia Fellow and Head of Anaesthetic Research at the Victorian Heart Hospital and Monash Health and Lachlan Miles is a Staff Specialist and Head of Research in the Department of Anaesthesia at Austin Health, Principal Research Fellow (and Honorary Principal Fellow) in the Department of Critical Care, University of Melbourne, Visiting Clinical Fellow and Clinical Lead (Perioperative) in Stroke and Critical Care Research at The Florey Institute and an editor for the medical journal Anaesthesia Reports.

Perry describes the lack of prior randomized trials in cardiac surgery despite decades of debate, reliance on low-quality retrospective data, and guideline calls for better evidence, and explains patient acceptability given rare but catastrophic PAC complications. The team outlines site eligibility based on PAC experience, a pragmatic non-inferiority design with a primary estimand of days alive and at home at 30 days, and allowance (but discouragement) of alternative minimally invasive cardiac output monitors. They discuss pilot recruitment success, securing MRFF funding, international expansion, and briefly compare equipoise around TOE/TEE use.

TopMedTalk is the broadcasting arm of EBPOM find out more at www.ebpom.org

Altri episodi di "TopMedTalk"